Neurology Minute podcast

The Amyloid Hypothesis for Alzheimer's disease and Aducanumab

0:00
1:57
Reculer de 15 secondes
Avancer de 15 secondes

Dr. Erik Musiek discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer's disease.

D'autres épisodes de "Neurology Minute"